Back to search
Ganglioneuroblastoma, Nodular
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ganglioneuroblastoma, Nodular trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Ganglioneuroblastoma, Nodular trials you may qualify forThis phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, r…
This phase III trial studies iobenguane I-131 or lorlatinib and standard therapy in treating younger patients with newly-diagnosed high-risk neuroblastoma or ga…
This phase II trial evaluates whether an investigational scan (18F-MFBG positron emission tomography \[PET\]/computed tomography \[CT\] or PET/magnetic resonanc…
This phase II trial studies if dinutuximab, GM-CSF, isotretinoin in combination with irinotecan, and temozolomide (chemo-immunotherapy) can be given safely to p…